Recombinomics | Elegant Evolution






Home Founder What's New In The News Consulting





























H1N1 Consulting

Paradigm Shift

Viral Evolution

Intervention Monitoring

Vaccine Screening

Vaccine Development

Expression Profiling

Drug Discovery

Custom Therapies

Patents 




Audio:Sep19 Oct 17 Nov 13 MAP RSS Feed twitter News Now                         

Commentary

Spain MERS Hajj Cluster Raises Concerns
Recombinomics Commentary 23:30
November 18, 2013

During the investigation of contacts of the case mentioned, a woman who belonged to the same group tour, with whom he shared the hotel room in Saudi Arabia , has been successful in one of the laboratory tests for the new coronavirus
 
The above translation, from a November 14 alert from the Department of Public Health in Spain describes a second lab confirmed MERS case in Spain in a Hajj pilgrim.  A media report indicated both cases have recovered and have been discharged, but the disease onset date for the second case is still unclear.

The first case (61M) had traveled to the Kingdom of Saudi Arabia from Spain on October 1.  She developed symptoms on October 15 shortly after she arrived in Mecca from Medina, suggesting she was infected in Medina and was symptomatic during the Hajj.  On October 28 she sought medical attention at a hospital in Mecca and was diagnosed as have pneumonia because on a clinical x-ray.  However, she refused admission and flew from Jeddah to Madrid (see map), where she developed breathing difficulties and was administered oxygen in flight.

She was MERS lab confirmed in Madrid and contacts were investigated.  The above alert indicated testing was still ongoing on additional contacts raising concerns that more cases will be confirmed.
Release of disease onset dates for the above case would be useful.

Media Link

Recombinomics Presentations

Recombinomics Publications

Recombinomics Paper at Nature Precedings















Home | Founder | What's New | In The News | Contact Us

Webmaster: webmaster@recombinomics.com
© 2013 Recombinomics.  All rights reserved.